Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Sherman

Showing results (371-380 of 390) with videos related to

Pageof 39
Sort By:
The Lancet. Infectious Diseases|January 10, 2026
Safety and immunogenicity of PanChol, a single-dose live-attenuated oral cholera vaccine: results from a phase 1a, double-blind, randomised, placebo-controlled trialDeborah R Leitner, Stephen R Walsh, Masataka Suzuki, et al.
Research Square|January 4, 2023
The mRNA vaccine BNT162b2 demonstrates impaired T<sub>H</sub>1 immunogenicity in human elders <i>in vitro</i> and aged mice <i>in vivo</i>Byron Brook, Benoit Fatou, Abhinav Kumar Checkervarty, et al.
Journal of Clinical Microbiology|October 17, 2020
COVID-19 Serology at Population Scale: SARS-CoV-2-Specific Antibody Responses in SalivaNora Pisanic, Pranay R Randad, Kate Kruczynski, et al.
Immunity|May 9, 2025
Computationally designed proteins mimic antibody immune evasion in viral evolutionNoor Youssef, Sarah Gurev, Fadi Ghantous, et al.
Frontiers in Public Health|December 10, 2021
Application of SARS-CoV-2 Serology to Address Public Health PrioritiesAmy C Sherman, Teresa Smith, Yerun Zhu, et al.
Vaccine|November 30, 2025
Evaluation of the safety and immunogenicity of two fractional intradermal regimens of MVA-BN compared to standard dose vaccinationSharon E Frey, Lindsey R Baden, Hana M El Sahly, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 28, 2025
Comparative Outcomes of Babesiosis in Immunocompromised and Non-Immunocompromised Hosts: A Multicenter Cohort StudyLoukas Kakoullis, Carolyn D Alonso, Rebecca Burns, et al.
Head & Neck|May 17, 2014
Measuring quality of life in patients with head and neck cancer: Update of the EORTC QLQ-H&N Module, Phase IIISusanne Singer, Cláudia Araújo, Juan Ignacio Arraras, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 16, 2025
Protracted SARS-CoV-2 Infection in B-cell Depleted Patients: Immunologic andiral Characteristics and Response to Dual and Extended Antiviral TherapyJessica S Little, Gregory E Edelstein, Zoe Swank, et al.
European Journal of Cancer (Oxford, England : 1990)|October 15, 2024
The european organisation for research and treatment of cancer head and neck cancer module (EORTC QLQ-HN43): Estimates for minimal important difference and minimal important changeSusanne Singer, Eva Hammerlid, Iwona M Tomaszewska, et al.
Pageof 39

Showing results (371-380 of 390) with videos related to

Sort By:
Pageof 39
The Lancet. Infectious Diseases|January 10, 2026
Safety and immunogenicity of PanChol, a single-dose live-attenuated oral cholera vaccine: results from a phase 1a, double-blind, randomised, placebo-controlled trialDeborah R Leitner, Stephen R Walsh, Masataka Suzuki, et al.
Research Square|January 4, 2023
The mRNA vaccine BNT162b2 demonstrates impaired T<sub>H</sub>1 immunogenicity in human elders <i>in vitro</i> and aged mice <i>in vivo</i>Byron Brook, Benoit Fatou, Abhinav Kumar Checkervarty, et al.
Journal of Clinical Microbiology|October 17, 2020
COVID-19 Serology at Population Scale: SARS-CoV-2-Specific Antibody Responses in SalivaNora Pisanic, Pranay R Randad, Kate Kruczynski, et al.
Immunity|May 9, 2025
Computationally designed proteins mimic antibody immune evasion in viral evolutionNoor Youssef, Sarah Gurev, Fadi Ghantous, et al.
Frontiers in Public Health|December 10, 2021
Application of SARS-CoV-2 Serology to Address Public Health PrioritiesAmy C Sherman, Teresa Smith, Yerun Zhu, et al.
Vaccine|November 30, 2025
Evaluation of the safety and immunogenicity of two fractional intradermal regimens of MVA-BN compared to standard dose vaccinationSharon E Frey, Lindsey R Baden, Hana M El Sahly, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 28, 2025
Comparative Outcomes of Babesiosis in Immunocompromised and Non-Immunocompromised Hosts: A Multicenter Cohort StudyLoukas Kakoullis, Carolyn D Alonso, Rebecca Burns, et al.
Head & Neck|May 17, 2014
Measuring quality of life in patients with head and neck cancer: Update of the EORTC QLQ-H&N Module, Phase IIISusanne Singer, Cláudia Araújo, Juan Ignacio Arraras, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 16, 2025
Protracted SARS-CoV-2 Infection in B-cell Depleted Patients: Immunologic andiral Characteristics and Response to Dual and Extended Antiviral TherapyJessica S Little, Gregory E Edelstein, Zoe Swank, et al.
European Journal of Cancer (Oxford, England : 1990)|October 15, 2024
The european organisation for research and treatment of cancer head and neck cancer module (EORTC QLQ-HN43): Estimates for minimal important difference and minimal important changeSusanne Singer, Eva Hammerlid, Iwona M Tomaszewska, et al.
Pageof 39